News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

MedCI Announces Strategic Alliance With Genta Incorporated (GETA.OB) to Secure Tesetaxel Licensing Partner


1/27/2010 10:17:34 AM

SANTA CLARA, Calif.--(BUSINESS WIRE)--MedCI LLC, a life-science business consulting services company, announced the formation of a new strategic alliance with Genta Incorporated (OTCBB:GETA) to secure licensing partners for Genta’s small molecule oncology compound, tesetaxel. Tesetaxel is the leading oral taxane in clinical development and is a core component of Genta’s investigational drug portfolio. Under the agreement, MedCI will continue and extend current discussions with leading pharmaceutical companies in South Korea that focus on oncology.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES